150 related articles for article (PubMed ID: 33512780)
1. The action of hyaluronan in functional properties, morphology and expression of matrix effectors in mammary cancer cells depends on its molecular size.
Tavianatou AG; Piperigkou Z; Koutsakis C; Barbera C; Beninatto R; Franchi M; Karamanos NK
FEBS J; 2021 Jul; 288(14):4291-4310. PubMed ID: 33512780
[TBL] [Abstract][Full Text] [Related]
2. Molecular size-dependent specificity of hyaluronan on functional properties, morphology and matrix composition of mammary cancer cells.
Tavianatou AG; Piperigkou Z; Barbera C; Beninatto R; Masola V; Caon I; Onisto M; Franchi M; Galesso D; Karamanos NK
Matrix Biol Plus; 2019 Aug; 3():100008. PubMed ID: 33543007
[TBL] [Abstract][Full Text] [Related]
3. Sulfated Hyaluronan Modulates the Functional Properties and Matrix Effectors Expression of Breast Cancer Cells with Different Estrogen Receptor Status.
Koutsakis C; Tavianatou AG; Kokoretsis D; Baroutas G; Karamanos NK
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944559
[TBL] [Abstract][Full Text] [Related]
4. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors.
Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS
Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
Piperigkou Z; Franchi M; Götte M; Karamanos NK
Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of hyaluronan oligosaccharides for bone metastasis of breast cancer.
Urakawa H; Nishida Y; Knudson W; Knudson CB; Arai E; Kozawa E; Futamura N; Wasa J; Ishiguro N
J Orthop Res; 2012 Apr; 30(4):662-72. PubMed ID: 21913222
[TBL] [Abstract][Full Text] [Related]
7. Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transition.
Karamanou K; Franchi M; Piperigkou Z; Perreau C; Maquart FX; Vynios DH; Brézillon S
Sci Rep; 2017 Mar; 7():45138. PubMed ID: 28332606
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid.
Dedes PG; Gialeli Ch; Tsonis AI; Kanakis I; Theocharis AD; Kletsas D; Tzanakakis GN; Karamanos NK
Biochim Biophys Acta; 2012 Dec; 1820(12):1926-39. PubMed ID: 22884656
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of lumican effects on morphology of invading breast cancer cells, expression of integrins and downstream signaling.
Karamanou K; Franchi M; Onisto M; Passi A; Vynios DH; Brézillon S
FEBS J; 2020 Nov; 287(22):4862-4880. PubMed ID: 32160387
[TBL] [Abstract][Full Text] [Related]
10. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
[TBL] [Abstract][Full Text] [Related]
11. Dynamic interplay between breast cancer cells and normal endothelium mediates the expression of matrix macromolecules, proteasome activity and functional properties of endothelial cells.
Gialeli Ch; Viola M; Barbouri D; Kletsas D; Passi A; Karamanos NK
Biochim Biophys Acta; 2014 Aug; 1840(8):2549-59. PubMed ID: 24582970
[TBL] [Abstract][Full Text] [Related]
12. ΕGFR/ERβ-Mediated Cell Morphology and Invasion Capacity Are Associated with Matrix Culture Substrates in Breast Cancer.
Kyriakopoulou K; Riti E; Piperigkou Z; Koutroumanou Sarri K; Bassiony H; Franchi M; Karamanos NK
Cells; 2020 Oct; 9(10):. PubMed ID: 33050027
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor beta modulates breast cancer cells functional properties, signaling and expression of matrix molecules.
Piperigkou Z; Bouris P; Onisto M; Franchi M; Kletsas D; Theocharis AD; Karamanos NK
Matrix Biol; 2016 Dec; 56():4-23. PubMed ID: 27179695
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo.
Urakawa H; Nishida Y; Wasa J; Arai E; Zhuo L; Kimata K; Kozawa E; Futamura N; Ishiguro N
Int J Cancer; 2012 Jan; 130(2):454-66. PubMed ID: 21387290
[TBL] [Abstract][Full Text] [Related]
15. The natural antisense transcript HAS2-AS1 regulates breast cancer cells aggressiveness independently from hyaluronan metabolism.
Parnigoni A; Caon I; Teo WX; Hua SH; Moretto P; Bartolini B; Viola M; Karousou E; Yip GW; Götte M; Heldin P; Passi A; Vigetti D
Matrix Biol; 2022 May; 109():140-161. PubMed ID: 35395387
[TBL] [Abstract][Full Text] [Related]
16. Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides.
Ween MP; Hummitzsch K; Rodgers RJ; Oehler MK; Ricciardelli C
Clin Exp Metastasis; 2011 Feb; 28(2):113-25. PubMed ID: 21153687
[TBL] [Abstract][Full Text] [Related]
17. Syndecan-1 Depletion Has a Differential Impact on Hyaluronic Acid Metabolism and Tumor Cell Behavior in Luminal and Triple-Negative Breast Cancer Cells.
Valla S; Hassan N; Vitale DL; Madanes D; Spinelli FM; Teixeira FCOB; Greve B; Espinoza-Sánchez NA; Cristina C; Alaniz L; Götte M
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070901
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronan synthase 2 overexpression is correlated with the tumorigenesis and metastasis of human breast cancer.
Li P; Xiang T; Li H; Li Q; Yang B; Huang J; Zhang X; Shi Y; Tan J; Ren G
Int J Clin Exp Pathol; 2015; 8(10):12101-14. PubMed ID: 26722395
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor-mediated targeting of the extracellular matrix network in cancer.
Piperigkou Z; Karamanos NK
Semin Cancer Biol; 2020 May; 62():116-124. PubMed ID: 31310807
[TBL] [Abstract][Full Text] [Related]
20. Effects of hyaluronan on the invasive properties of human breast cancer cells in vitro.
Herrera-Gayol A; Jothy S
Int J Exp Pathol; 2001 Jun; 82(3):193-200. PubMed ID: 11488992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]